Spero Therapeutics, Inc. (SPRO) Revenue 2016–2025
Spero Therapeutics, Inc. (SPRO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$12.6MFY2025 · since FY2016: $335,000 → $12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.6M | +3292.5% |
| FY2024 | $371,000 | -60.2% |
| FY2023 | $933,000 | -62.7% |
| FY2022 | $2.5M | -18.5% |
| FY2021 | $3.1M | +1089.9% |
| FY2020 | $258,000 | -94.6% |
| FY2019 | $4.7M | +19.6% |
| FY2018 | $4.0M | +100.4% |
| FY2017 | $2.0M | +490.7% |
| FY2016 | $335,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRO financial trends
SPRO Net incomeSPRO Net marginSPRO Gross profitSPRO Gross marginSPRO Operating incomeSPRO Operating marginSPRO Operating cash flowSPRO Free cash flowSPRO Capital expendituresSPRO Return on equitySPRO Stock buybacksSPRO Dividends paidSPRO Total assetsSPRO Total liabilitiesSPRO Shareholders’ equitySPRO overview →